DS
VIR icon

DRW Securities’s Vir Biotechnology VIR Stock Holding History

DRW Securities’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$144K Sell
14,108
-19,508
-58% -$186K ﹤0.01% 838
2026
Q1 		$301K Buy
33,616
+21,701
+182% +$173K ﹤0.01% 894
2025
Q4 		$71.8K Buy
+11,915
New +$70.9K ﹤0.01% 1095

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DRW Securities's VIR Position: Q2 2026 in Review

DRW Securities reduced its Vir Biotechnology (VIR) stake by 58% in Q2 2026, selling an estimated $186K and leaving 14,108 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #838.

DRW Securities first reported a position in VIR in Q4 2025 and has held it in 3 quarters since. The position peaked at $301K in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • DRW Securities held 14,108 shares of Vir Biotechnology worth $144K as of Q2 2026.
  • DRW Securities sold 19,508 Vir Biotechnology shares in Q2 2026, an estimated $186K.
  • Vir Biotechnology made up ﹤0.01% of DRW Securities's portfolio in Q2 2026, its #838 holding.
  • DRW Securities first reported a position in Vir Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • DRW Securities's Vir Biotechnology position peaked at $301K in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.